Five things to know:
1. Fourth-quarter revenue was $46.4 million, a 6.2 percent year-over-year increase.
2. Sales of new and recently launched products drove sales, making up 68 percent of total sales. The company’s spinal implants and orthobiologics revenue made up the other 35 percent of sales.
3. Fourth-quarter international revenue decreased 3.2 percent to $4.3 million.
4. For the full year, SeaSpine reported U.S. revenues of $138.9 million, a 2.1 percent year-over-year decrease.
5. SeaSpine posted a net loss of $43.2 million for 2020, up from $39.3 million in 2019.
Keith Valentine, president and CEO of SeaSpine, said, “Despite all the uncertainty and disruption we faced in 2020, the entire SeaSpine organization remained committed to our mission to deliver cost effective spinal implants and orthobiologics procedural solutions to surgeons and hospitals to improve the quality of patient lives.”
More articles on physicians:
Physician pay under Stark Law’s final rule: 4 takeaways on fair market value
Physician practices are a hot target: 45 sales in January
Dr. Michael Ast: 3 ways orthopedics, ASCs will change in the next 3 years
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.